middle.news
EBR Systems Secures A$55.9M to Launch FDA-Approved Wireless Cardiac Device
1:52am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
EBR Systems Secures A$55.9M to Launch FDA-Approved Wireless Cardiac Device
1:52am on Monday 2nd of June, 2025 AEST
Key Points
A$55.9 million institutional placement at A$1.00 per CDI completed
FDA-approved WiSE CRT system targeting limited market release in H2 2025
CMS inpatient reimbursement eligibility confirmed; outpatient pending final approval
Pro-forma cash balance of US$84 million supports operations into Q4 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ebr Systems (ASX:EBR)
OPEN ARTICLE